TPST Financials

Tempest Therapeutics Inc - Financial statements & key metrics

Stock Price

$1.05

Market Cap

$26.26M

P/E Ratio

-0.7

EPS

$-1.50

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-41.84M

EPS (Diluted)

$-1.50

Balance Sheet Highlights

Total Assets

$41.49M

Total Liabilities

$22.36M

Shareholders Equity

Cash & Equivalents

$30.27M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-33.03M

CapEx

Free Cash Flow

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is TPST revenue?

View TPST's income statement for detailed revenue data.

Is TPST profitable?

TPST reported a loss of $41.84M in the most recent quarter.

What is TPST market cap?

TPST has a market capitalization of $26.26M, making it a small-cap stock.

Does TPST have debt?

View TPST's balance sheet for debt information.

What is TPST cash flow?

Cash flow data is available in the full financial statements.